This inventor holds 1 USPTO granted patent. Top assignee: Kaken Pharmaceutical Company, Ltd.. Active years: 1986.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1986
Title: Innovator Yoshitaka Takehisa: Pioneering Rhodanines for Diabetic Complications
Introduction: Yoshitaka Takehisa, a distinguished inventor based in Omihachiman, Japan, has made significant contributions to pharmaceutical innovations through his research and development efforts. With a focus on solutions for diabetic complications, his work reflects a dedicated commitment to improving health outcomes for patients.
Latest Patents: Takehisa holds a notable patent concerning rhodanines, specifically titled "Rhodanines Useful as a Therapeutic Agent for Diabetic Complications." This innovation features a rhodanine derivative represented by a specific general formula, where R is an acyclic alkyl group ranging from 2 to 10 carbon atoms or an acyclic alkenyl group having 2 to 19 carbon atoms. The compound has demonstrated potent platelet aggregation inhibiting and aldose reductase inhibiting activities, showcasing its potential as a therapeutic agent for managing diabetes-related complications.
Career Highlights: Yoshitaka Takehisa is affiliated with Kaken Pharmaceutical Company, Ltd., a leading organization in the field of pharmaceutical research and development. His role within the company emphasizes his expertise and contributions to the advancement of medical therapies, particularly those addressing the challenges of chronic conditions like diabetes.
Collaborations: Throughout his career, Takehisa has collaborated with talented colleagues, including Yoshitaka Ohishi and Michiko Nagahara. Their teamwork has contributed to innovative research and the successful development of new therapeutic agents, enhancing the capabilities of their pharmaceutical endeavors.
Conclusion: As a key figure in the pharmaceutical landscape, Yoshitaka Takehisa exemplifies the impact of innovation on healthcare. His patent on rhodanines reflects a meaningful stride towards combating diabetic complications, ultimately leading to better health solutions for patients worldwide. His ongoing work at Kaken Pharmaceutical Company, Ltd. ensures that he remains at the forefront of scientific advancements in the medical field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile